Nuzenio

Mutated Breast Cancer

Mutated Breast Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Sethera Therapeutics’ Polymacrocyclic Peptide Platform Selected for CDMRP-Supported Mutant p53 Breast Cancer Program | Newswise - NewswiseNewswise · Mon, 10 Aug 2026 11:00:00 GMT Veliparib: Mechanism, Dose, Administration, And Clinical Trials - OncodailyOncodaily · Sun, 09 Aug 2026 10:16:14 GMT FDA Flashback: Breast Cancer Decisions and News From July 2026 - OncLiveOncLive · Thu, 06 Aug 2026 22:03:53 GMT Vepdegestrant (Veppanu) Approved by FDA - Breast Cancer.orgBreast Cancer.org · Tue, 04 Aug 2026 07:00:00 GMT Examining the Implications of the VIKTORIA-1 Study 2 Data in PIK3CA-Mutated Breast Cancer - OncLiveOncLive · Fri, 31 Jul 2026 07:00:00 GMT Advancements in Breast Cancer Research - HealthCentralHealthCentral · Wed, 29 Jul 2026 07:00:00 GMT Matthew Kurian: Sequencing for ESR1/PIK3CA Co-Mutated Metastatic Breast Cancer - OncodailyOncodaily · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 11:00:00 GMTSethera Therapeutics’ Polymacrocyclic Peptide Platform Selected for CDMRP-Supported Mutant p53 Breast Cancer Program | Newswise - Newswise

Sun, 09 Aug 2026 10:16:14 GMTVeliparib: Mechanism, Dose, Administration, And Clinical Trials - Oncodaily

Thu, 06 Aug 2026 22:03:53 GMTFDA Flashback: Breast Cancer Decisions and News From July 2026 - OncLive

Tue, 04 Aug 2026 07:00:00 GMTVepdegestrant (Veppanu) Approved by FDA - Breast Cancer.org

Fri, 31 Jul 2026 07:00:00 GMTExamining the Implications of the VIKTORIA-1 Study 2 Data in PIK3CA-Mutated Breast Cancer - OncLive

Wed, 29 Jul 2026 07:00:00 GMTAdvancements in Breast Cancer Research - HealthCentral

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Polymacrocyclic Peptide Platform2 live mentions Selected2 live mentions CDMRP2 live mentions Supported Mutant2 live mentions Breast Cancer Program2 live mentions Mechanism2 live mentions Dose2 live mentions Administration2 live mentions And Clinical Trials2 live mentions Breast Cancer Decisions2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mutated Breast Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.